GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » EV-to-FCF

Lonza Group (Lonza Group) EV-to-FCF : -134.72 (As of Apr. 28, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Lonza Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lonza Group's Enterprise Value is $43,362 Mil. Lonza Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-322 Mil. Therefore, Lonza Group's EV-to-FCF for today is -134.72.

The historical rank and industry rank for Lonza Group's EV-to-FCF or its related term are showing as below:

LZAGY' s EV-to-FCF Range Over the Past 10 Years
Min: -454.59   Med: 28.83   Max: 391.7
Current: -134.45

During the past 13 years, the highest EV-to-FCF of Lonza Group was 391.70. The lowest was -454.59. And the median was 28.83.

LZAGY's EV-to-FCF is ranked worse than
100% of 103 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.94 vs LZAGY: -134.45

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-28), Lonza Group's stock price is $57.79. Lonza Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.001. Therefore, Lonza Group's PE Ratio for today is 57.73.


Lonza Group EV-to-FCF Historical Data

The historical data trend for Lonza Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group EV-to-FCF Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 165.30 290.70 -452.75 -40.01 -91.94

Lonza Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -452.75 - -40.01 - -91.94

Competitive Comparison of Lonza Group's EV-to-FCF

For the Diagnostics & Research subindustry, Lonza Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lonza Group's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lonza Group's EV-to-FCF falls into.



Lonza Group EV-to-FCF Calculation

Lonza Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=43362.154/-321.858
=-134.72

Lonza Group's current Enterprise Value is $43,362 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-322 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lonza Group  (OTCPK:LZAGY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lonza Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=57.79/1.001
=57.73

Lonza Group's share price for today is $57.79.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lonza Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lonza Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lonza Group (Lonza Group) Business Description

Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.